ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
CStone submits an abstract on CS1001-201 trial to 2019 ASH Annual Meeting
August 21, 2019The CS1001-201 trial reported in the abstract is a single-arm, multi-centre Phase II clinical study designed to evaluate the efficacy, safety, pharmacokinetics, and immunogenicity of CS1001 monotherapy in relapsed or refractory extranodal natural killer ( -
AstraZeneca heads to 2018 ASCO Annual Meeting with its diversified oncology portfolio and next-generation pipeline
June 05, 2018AstraZeneca and MedImmune, its global biologics research and development arm, head to the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago
Pharma Sources Insight January 2025
